Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study
© 2019 The British Pharmacological Society Aims: Sodium glucose co-transporter-2 inhibitors have been shown to reduce cardiovascular events and heart failure in type 2 diabetic (T2D) patients with high cardiovascular risk. Dipeptidyl peptidase-4 inhibitors showed neutral effects and may increase ris...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | 雜誌 |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064487765&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65738 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|